Review
The development of new drugs for the treatment of schizophrenia
Affiliations
- PMID: 2893648
Item in Clipboard
Review
The development of new drugs for the treatment of schizophrenia
Br J Hosp Med.
1987 Dec.
Abstract
Currently available anti-psychotic drugs owe much of their efficacy in schizophrenia to their ability to block dopamine receptors in specific areas of the brain. This article reviews the mechanisms action and side effects of drugs used for schizophrenia, and describes approaches to the development of new treatments.
Similar articles
-
Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.Br J Psychiatry Suppl. 1994 Apr;(23):65-70. Br J Psychiatry Suppl. 1994. PMID: 7913610 Review.
-
Towards more effective antipsychotic treatment.Br J Psychiatry Suppl. 1994 Nov;(25):22-31. Br J Psychiatry Suppl. 1994. PMID: 7865194 Review.
-
The complexity of the dopaminergic synapses and their modulation by antipsychotics.Pharmacopsychiatry. 2006 Feb;39 Suppl 1:S15-20. doi: 10.1055/s-2006-931484. Pharmacopsychiatry. 2006. PMID: 16508891
-
The neurochemical circuitry of schizophrenia.Pharmacopsychiatry. 2006 Feb;39 Suppl 1:S10-4. doi: 10.1055/s-2006-931483. Pharmacopsychiatry. 2006. PMID: 16508890
-
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.Mol Psychiatry. 2005 Jan;10(1):79-104. doi: 10.1038/sj.mp.4001556. Mol Psychiatry. 2005. PMID: 15289815 Review.
Cited by
-
Liver and pituitary abnormalities in Hallervorden-Spatz disease.J Neurol Neurosurg Psychiatry. 1989 Dec;52(12):1410-4. doi: 10.1136/jnnp.52.12.1410. J Neurol Neurosurg Psychiatry. 1989. PMID: 2614437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical